Validation of the tremor biomechanics analysis laboratory (TREMBAL) software in MS tremor

A Van der Walt; FMC Boonstra; SAC Yohanandan; AP Vogel; SC Kolbe; J Ly; G Noffs; H Butzkueven; AH Evans; T Perera

Conference Proceedings

Validation of the tremor biomechanics analysis laboratory (TREMBAL) software in MS tremor

A Van der Walt, FMC Boonstra, SAC Yohanandan, AP Vogel, SC Kolbe, J Ly, G Noffs, H Butzkueven, AH Evans, T Perera

MULTIPLE SCLEROSIS JOURNAL | SAGE PUBLICATIONS LTD | Published : 2016

Abstract

Type: Poster Abstract Category: Clinical aspects of MS - Clinical assessment tools Background: Tremor in MS (MST) is difficult to treat and the development of new interventions is limited by the absence of universal measuring systems. At present, therapeutic outcomes are measured by a variety of clinical rating scales that are subjective and lack sufficient sensitivity. With increasing use of interventional treatments such as Botulinum toxin injections or Deep Brain Stimulation for MST, it has become critical to develop precise measurement instruments. Objective: To clinically validate the TREMBAL software in MST. Methods: TREMBAL (Bionics Institute, Melbourne, Australia) utilises an el..

View full abstract

University of Melbourne Researchers

Adam Vogel Author Audiology and Speech Pathology

Helmut Butzkueven Author Medicine - Royal Melbourne Hospital

Scott Kolbe Author Radiology

Related Projects (1)

Communication And Swallowing Outcomes In Patients With Acquired And Progressive Neurological Disorders

We all talk, eat and drink, but it’s not until we lose these skills that we recognise their importance. Communication & swallowing disorders..

Grants

Funding Acknowledgements

H. Butzkueven served on advisory boards for Biogen, Novartis and Sanofi and has received conference travel support from Novartis, Biogen and Sanofi. He serves on steering committees for trials conducted by Biogen and Novartis, and has receivedresearch support from Merck Serono, Novartis and Biogen.